200 related articles for article (PubMed ID: 30617596)
21. Cancer in association with polymyalgia rheumatica and temporal arteritis.
Haga HJ; Eide GE; Brun J; Johansen A; Langmark F
J Rheumatol; 1993 Aug; 20(8):1335-9. PubMed ID: 8230015
[TBL] [Abstract][Full Text] [Related]
22. Ischemic stroke caused by giant cell arteritis associated with pulmonary adenocarcinoma.
Scopelliti G; Bertora P; Bortolami C; Rosa S; Pantoni L
J Clin Neurosci; 2020 Feb; 72():485-486. PubMed ID: 31694779
[TBL] [Abstract][Full Text] [Related]
23. [Giant cell arteritis. A study of 191 patients].
Armona J; Rodríguez-Valverde V; González-Gay MA; Figueroa M; Fernández-Sueiro JL; Blanco R; Martínez-Taboada V
Med Clin (Barc); 1995 Dec; 105(19):734-7. PubMed ID: 8523954
[TBL] [Abstract][Full Text] [Related]
24. Primary biliary cirrhosis, temporal arteritis (giant cell arteritis) and polymyalgia rheumatica in a single patient.
Gagnerie F; Taillan B; Euller-Ziegler L; Ziegler G
Scand J Rheumatol; 1988; 17(3):231-2. PubMed ID: 2902684
[TBL] [Abstract][Full Text] [Related]
25. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
Becker M
Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
[TBL] [Abstract][Full Text] [Related]
26. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
[TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.
Espinosa G; Tàssies D; Font J; Muñoz-Rodríguez FJ; Cervera R; Ordinas A; Reverter JC; Ingelmo M
Semin Arthritis Rheum; 2001 Aug; 31(1):12-20. PubMed ID: 11503135
[TBL] [Abstract][Full Text] [Related]
28. Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
Liozon E; Delmas C; Dumonteil S; Dumont A; Gondran G; Bezanahary H; Aouba A; Fauchais AL; Ly KH; de Boysson H
Semin Arthritis Rheum; 2019 Oct; 49(2):288-295. PubMed ID: 30910217
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
Myklebust G; Gran JT
Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
[TBL] [Abstract][Full Text] [Related]
30. Pericardial effusion in giant cell arteritis is associated with increased inflammatory markers: a retrospective cohort study.
Gomes de Pinho Q; Daumas A; Benyamine A; Bertolino J; Rossi P; Schleinitz N; Harlé JR; Jarrot PA; Kaplanski G; Berbis J; Granel B
Rheumatol Int; 2022 Nov; 42(11):2013-2018. PubMed ID: 35525874
[TBL] [Abstract][Full Text] [Related]
31. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
32. Disease pattern in cranial and large-vessel giant cell arteritis.
Brack A; Martinez-Taboada V; Stanson A; Goronzy JJ; Weyand CM
Arthritis Rheum; 1999 Feb; 42(2):311-7. PubMed ID: 10025926
[TBL] [Abstract][Full Text] [Related]
33. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
[TBL] [Abstract][Full Text] [Related]
34. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
35. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids.
Andersson R; Malmvall BE; Bengtsson BA
Acta Med Scand; 1986; 220(4):361-4. PubMed ID: 3799241
[TBL] [Abstract][Full Text] [Related]
37. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
[TBL] [Abstract][Full Text] [Related]
38. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
39. [4 cases of Horton's temporal arteritis. Hypothesis on the possible correlations with rheumatic polymyalgia].
Ansaloni MC; Zizzi F; Giorgio M; Leandri P; Mantovani W; Montanari A; Reta M; Alessi A; Nasi C; Alberti T
Recenti Prog Med; 1994 Jan; 85(1):22-8. PubMed ID: 8184176
[TBL] [Abstract][Full Text] [Related]
40. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
